1. Assessment of human abuse potential of preladenant (a centrally-acting A2A antagonist) compared to phentermine and placebo in recreational stimulant users. (1st January 2015) Authors: Schoedel, Kerri; Levy-Cooperman, Naama; Basseches, Peter; Butterfield, Kristin; Hewitt, David; Larson, Pat; Troyer, Mattew; Sellers, Edward M.; de Haes, Joanna Udo Journal: Drug and alcohol dependence Issue: Volume 146(2015) Page Start: e91 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Molecular Neuroimaging of the Dopamine Transporter as a Patient Enrichment Biomarker for Clinical Trials for Early Parkinson's Disease. Issue 3 (18th March 2019) Authors: Romero, Klaus; Conrado, Daniela; Burton, Jackson; Nicholas, Timothy; Sinha, Vikram; Macha, Sreeraj; Ahamadi, Malidi; Cedarbaum, Jesse; Seibyl, John; Marek, Kenneth; Basseches, Peter; Hill, Derek; Somer, Ed; Gallagher, Jill; Dexter, David T.; Roach, Arthur; Stephenson, Diane Journal: Clinical and translational science Issue: Volume 12:Issue 3(2019) Page Start: 240 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗